Previous 10 | Next 10 |
CONMED Corporation (NYSE: CNMD) today announced that it has completed its previously announced acquisition of privately-held Biorez, Inc. Biorez is a medical device start-up based in New Haven, CT and is focused on advancing the healing of soft tissue using its proprietary BioBr...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
CONMED ( NYSE: CNMD ) on Monday said it would acquire privately-held medical device start-up Biorez for a cash consideration of $85M at closing and up to an additional $165M in growth-based earnout payments over a four-year period. CNMD said it expects the deal to add ...
Through this acquisition, CONMED acquires next generation bioinductive collagen scaffold technology for application in sports medicine soft tissue healing CONMED to host conference call today at 4:30 p.m. ET CONMED Corporation (NYSE: CNMD) today a...
CONMED Corporation (CNMD) Q2 2022 Earnings Conference Call July 27, 2022 04:30 PM ET Company Participants Curt Hartman - Chairman, President & Chief Executive Officer Pat Beyer - President, CONMED International & Global Orthopaedics Todd Garner - Executiv...
The following slide deck was published by CONMED Corporation in conjunction with their 2022 Q2 earnings call. For further details see: CONMED Corporation 2022 Q2 - Results - Earnings Call Presentation
CONMED press release ( NYSE: CNMD ): Q2 Non-GAAP EPS of $0.76 beats by $0.01 . Revenue of $277.19M (+23.1% Y/Y) beats by $2.97M . The Company lowered its revenue guidance for the full year 2022 and now expects revenue between $1.095 billion and $1.140 billion c...
CONMED Corporation (NYSE: CNMD) today announced financial results for the second quarter ended June 30, 2022. Second Quarter 2022 Highlights Sales of $277.2 million increased 8.6% year over year as reported and 9.8% in constant currency. Acquisitions contributed approx...
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the second quarter 2022 after the market close on Wednesday, July 27, 2022. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. ...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
News, Short Squeeze, Breakout and More Instantly...
Conmed Corp. - Ordinary Shares Company Name:
CNMD Stock Symbol:
NASDAQ Market:
Conmed Corp. - Ordinary Shares Website:
2024-07-18 18:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
CONMED Corporation (NYSE: CNMD) today announced it will report financial results for the second quarter of 2024 after the market close on Wednesday, July 31, 2024. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participat...
2024-07-08 16:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...